Guinea vs Slovenia: Access to anti-retroviral drugs, female
Guinea
83.0%
in 2024
Slovenia
83.0%
in 2024
Guinea rank
53rd
Slovenia rank
53rd
Access to anti-retroviral drugs, female over time
- Guinea
- Slovenia
How they compare
Guinea currently reports 83.0% against 83.0% in Slovenia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Slovenia ahead.
Guinea ranks 53rd and Slovenia ranks 53rd of 141 countries.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 28.3% | 24.6% | Slovenia |
| 2010s | 32.7% | 57.1% | 24.4% | Slovenia |
| 2020s | 70.2% | 73.8% | 3.6% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Guinea or Slovenia?
- Guinea, at 83.0% against 83.0% in Slovenia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Guinea and Slovenia?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Slovenia?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea and Slovenia rank globally for access to anti-retroviral drugs, female?
- Guinea ranks 53rd and Slovenia ranks 53rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.